1 Min Read
April 3 (Reuters) - Ampio Pharmaceuticals Inc:
* RETAINED PAREXEL TO ASSIST IN PREPARING AND PRESENTING BLA FOR AMPION FOR TREATMENT OF OSTEOARTHRITIS-OF—KNEE TO FDA Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.